Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiocontrast-induced nephropathy.

Arif Asif1, Richard A Preston, David Roth

  • 1Division of Nephrology and Hypertension, Department of Medicine, University of Miami School of Medicine, 1600 NW 10th Avenue (R 7168), Miami, FL 33136, USA.

American Journal of Therapeutics
|March 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling tariff-induced network failure and hysteresis.

Physical review. E·2026
Same author

A journey through veins: discovery to modern therapy.

Kidney research and clinical practice·2026
Same author

Acute blood pressure reduction exceeding safety and autoregulatory limits following rapid-acting antihypertensives for hypertensive urgency.

Journal of hypertension·2026
Same author

Comparison of Rifampin and Isoniazid for Latent Tuberculosis Infection in Kidney Transplant Candidates: Focus on Tolerability and Treatment Completion.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

[Hematochezia : when should we worry ?]

Revue medicale suisse·2025
Same author

Pharmacokinetics, safety, and tolerability of fedratinib in adults with moderate and severe hepatic impairment: results from the phase 1 FEDR-CP-001 trial.

Cancer chemotherapy and pharmacology·2025
Same journal

Deucravacitinib for Generalized Pustular Psoriasis and Comorbid Polymyositis: Dual Efficacy and Favorable Safety.

American journal of therapeutics·2026
Same journal

Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.

American journal of therapeutics·2026
Same journal

Do Not Treat a Sequencing Report: Therapeutic Stewardship in Endometrial Microbiome Testing.

American journal of therapeutics·2026
Same journal

Right Side Accessory Pathway Mediated Cardiomyopathy Treated with Amiodarone: First Adult Case Report.

American journal of therapeutics·2026
Same journal

Dose-Dependent Escitalopram-Induced Anejaculation and Anorgasmia: Rapid Reversal After Discontinuation and Bupropion Therapy.

American journal of therapeutics·2026
Same journal

Critical Appraisal of "Continued versus Interrupted Oral Anticoagulation During Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation: A Meta-Analysis".

American journal of therapeutics·2026
See all related articles

Radiocontrast-induced nephropathy (RIN) is a significant cause of acute kidney injury. Early diagnosis and prevention strategies are crucial, especially for at-risk patients with pre-existing renal insufficiency or diabetes.

Area of Science:

  • Nephrology
  • Radiology
  • Pharmacology

Background:

  • Radiocontrast administration is a leading cause of hospital-acquired acute renal failure.
  • Radiocontrast-induced nephropathy (RIN) presents as a sudden decline in renal function post-contrast.
  • RIN is associated with increased mortality, complications like sepsis, and extended hospital stays.

Observation:

  • Serum creatinine levels typically rise 24-72 hours post-contrast, peaking at 3-5 days.
  • Patients with pre-existing renal insufficiency and diabetes mellitus are at higher risk for RIN.
  • Previous preventive measures include hydration, diuretics, and various pharmacological agents.

Findings:

  • Fenoldopam (dopamine-1 agonist) and N-acetylcysteine show promise in ameliorating RIN.

Related Experiment Videos

  • These agents may offer a more effective approach to preventing contrast-induced nephropathy.
  • Further research into novel therapeutic interventions is warranted.

    • Implications:

    • Heightened awareness of RIN diagnosis and prevention is critical.
    • Identifying high-risk patients allows for targeted prophylactic strategies.
    • Effective prevention of RIN can reduce patient morbidity, mortality, and healthcare costs.